Skip to main content
Premium Trial:

Request an Annual Quote

RXi, UMMS Receive Massachusetts Life Sciences Center Funding for ALS Work

Premium

RXi Pharmaceuticals said this week that its planned collaboration with the University of Massachusetts Medical School to develop an RNAi-based treatment for amyotrophic lateral sclerosis has been selected for matching funding from the Massachusetts Life Sciences Center.

The funding is worth $250,000 per year for two years and will be matched dollar for dollar by RXi. The award is still subject to a formal agreement between RXi and UMMS.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.